A Study of Dulanermin Administered in Combination With the FOLFOX Regimen and Bevacizumab in Patients With Previously Untreated, Locally Advanced, Recurrent, or Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Bevacizumab
Related studies linked through entity extraction aliases.
Ursodiol, Combination Chemotherapy, and Bevacizumab in Treating Patients With Stage IV Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
MRI Scans of Blood Vessel Changes Caused by Bevacizumab Alone or Given Together With Interferon Alpha-2a in Treating Patients With Stage III or Stage IV Kidney Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Capecitabine and Bevacizumab ± Vinorelbine in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Trial of Pemetrexed and Bevacizumab for Recurrent Ovarian Primary Peritoneal Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Avastin in Patients With Epithelial Ovarian, Primary Peritoneal Serous or Fallopian Tube Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Bevacizumab (Avastin) in Participants With Newly Diagnosed Locally Advanced Rectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE2
To Evaluate the Safety, Tolerability and Pharmacokinetics of AMG 386 When Used in Combination With AMG 706, Bevacizumab, Sorafenib, or Sunitinib.
- Status
- COMPLETED
- Phase
- PHASE1
LBH589 and Bevacizumab in Patients With Recurrent High Grade Glioma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
S0800, Nab-Paclitaxel, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Sequential Angiogenic Blockade for the Treatment of Recurrent Mullerian Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Subconjunctival Bevacizumab Effect on Bleb Vascularity
- Status
- UNKNOWN
- Phase
- PHASE2
Does Adding Bevacizumab Therapy in Glaucoma Surgery Improve the Success of Needle Bleb Revisions?
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Bevacizumab and Aldesleukin in Treating Patients With Metastatic Clear Cell Carcinoma of the Kidney
- Status
- COMPLETED
- Phase
- PHASE2
A Study of PRO95780 Administered in Combination With the FOLFOX Regimen and Bevacizumab in Patients With Previously Untreated, Locally Advanced, Recurrent, and Metastatic Colorectal Cancer (APM4566g)
- Status
- COMPLETED
- Phase
- PHASE1
Ph II Trial of a Novel Anti-angiogenic Agent in Combination With Chemotherapy for the Second-line Treatment of Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Ph II of a Novel Anti-angiogenic Agent in Combination With Chemotherapy for the Treatment of Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Xeloda and Bevacizumab to Treat Rectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2